Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Illumina (ILMN), which belongs to the Zacks ...

Illumina, Inc. ILMN has announced a collaboration with NVIDIA NVDA to advance technology platforms for analyzing and interpreting multiomic data. By combining advancements in artificial intelligence ...

Bernstein analyst Eve Burstein maintained a Hold rating on Illumina (ILMN – Research Report) today. The company’s shares opened today at ...

Bank of America Securities analyst Michael Ryskin maintained a Sell rating on Illumina (ILMN – Research Report) today and set a price target of ...

Claro Advisors LLC lessened its holdings in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 17.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the ...

Genomics is becoming the future of medicine as technological advancements continue to unlock our DNA’s vast potential. Given ...

As of 3:44:31 PM EST. Market Open. Illumina, Inc. (NASDAQ: ILMN) ("Illumina" or the "company") today announced unaudited preliminary financial results for the fourth quarter and fiscal year 2024 ...

Illumina raises Q4 and FY24 revenue outlook, expects solid margins, with projected 2024 EPS between $4.12 and $4.14.

Buying $100 In ILMN: If an investor had bought $100 of ILMN stock 20 years ago, it would be worth $3,290.99 today based on a ...

Illumina Inc., based in San Diego, provides sequencing and array-based solutions for genetic analysis. The company's products and services are sold to genomic research centers, academic institutions, ...

Equities researchers at Leerink Partnrs lifted their Q1 2025 earnings estimates for Illumina in a report released on Tuesday, ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a pilot proteomics program to analyze 50,000 UK Biobank samples in collaboration with ...